Cue Biopharma Inc. (NASDAQ: CUE)
$0.93
+0.0020 ( +0.21% ) 279.9K
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
Market Data
Open
$0.93
Previous close
$0.93
Volume
279.9K
Market cap
$45.34M
Day range
$0.90 - $0.97
52 week range
$0.85 - $4.89
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
8-k | 8K-related | 11 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
8-k | 8K-related | 13 | May 09, 2024 |
10-q | Quarterly Reports | 72 | May 09, 2024 |
def | Proxies and info statements | 8 | Apr 26, 2024 |